Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2024Drugs & AgingOpen Access

Real-World Experience of Immune-Checkpoint Inhibitors in Older Patients with Advanced Cutaneous Squamous Cell Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

LMLuke McLeanALAnnette M. LimMBMathias Bressel

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

McLean et al. (2024) studied this question.

synapsesocial.com/papers/68e7634db6db6435876d953bhttps://doi.org/10.1007/s40266-024-01095-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study2019 · 56 citations
  2. 2Pembrolizumab Monotherapy for Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Arm Phase II Trial (KEYNOTE-629)2020 · 266 citations
  3. 3The effects of comorbidity on colorectal cancer mortality in an Australian cancer population2019 · 46 citations
  4. 4Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group2021 · 59 citations
  5. 5Immunotherapy in patients with autoimmune disease2020 · 30 citations